Osimertinib for the Treatment of EGFR Mutation-Positive Lung Adenocarcinoma Complicated With Dermatomyositis

Other users also viewed these articles

Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib Masahiro Yamasaki, Kunihiko Funaishi, Wakako Daido, Noboru Hattori

10.1016/j.arbres.2019.04.004

Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population Filipa Aguiar, Gabriela Fernandes, Henrique Queiroga, José Carlos Machado, Luís Cirnes, Conceição Souto Moura, Venceslau Hespanhol

10.1016/j.arbres.2017.07.012

Atypical Metastasis of Lung Adenocarcinoma Ângela Dias Cunha, Marta Sousa, Paula Sousa

10.1016/j.arbres.2020.04.001